ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Varmus Pledges to Keep Grants at 2010 Level As Federal Shutdown Looms

April 8, 2011

In Brief: NIH Budget Cut Being Considered, Threatening NCI’s Plan For Reaching Year 2000 Goals

December 13, 1984

In Brief: Baylor Campus to Build Joint Cancer Center

January 17, 2014

This month’s 8-page Business & Regulatory Report included in this issue.

January 30, 2004

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research

March 8, 1991